Big Health, a San Francisco, CA-based digital therapeutics company dedicated to mental health, raised $39m in Series B financing.
The round was led by Gilde Healthcare joined by co-lead Morningside Ventures; existing investors Kaiser Permanente Ventures (KPV) and Octopus Ventures; and Samsung NEXT. Janke Dittmer, general partner at Gilde and Isaac Cheng, partner at Morningside, will join the Big Health board, which also includes Liz Rockett (KPV), Alliott Cole (Octopus) and Arun Gupta (Founder, Quartet).
The company will use the funds to invest in new product development, expand its distribution channels, and scale its commercialization activities.
Founded by entrepreneur Peter Hames and Professor Colin Espie, the world sleep expert whose published research helped Peter overcome his insomnia, Big Health provides “digital therapeutics” — Daylight™, for worry & anxiety, and Sleepio™, for poor sleep, which are fully automated, scalable cognitive and behavioral programs. The products combine human voice, engaging animation, and clinically rigorous techniques to help people overcome their mental health challenges. They are backed by 50 published clinical papers including 13 randomised controlled trials (RCTs), and are cited in leading clinical guidelines including the American College of Physicians and NICE.